JCI
57
2
FLR
43
10
ALL
50
-7
ILMN
11
2
FDX
40
3
ECL
72
2
GLW
52
3
BWA
34
5
BRK.B
40
-2
KR
55
-2
SHW
53
-6
WM
79
2
DHI
31
3
PM
68
2
ROK
44
-2
UAL
70
7
ADI
60
5
DTE
75
3
HPE
38
4
MTB
55
5
JCI
57
2
FLR
43
10
ALL
50
-7
ILMN
11
2
FDX
40
3
ECL
72
2
GLW
52
3
BWA
34
5
BRK.B
40
-2
KR
55
-2
SHW
53
-6
WM
79
2
DHI
31
3
PM
68
2
ROK
44
-2
UAL
70
7
ADI
60
5
DTE
75
3
HPE
38
4
MTB
55
5
Financhill
Back

Palo Alto Networks Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
80

PANW
Palo Alto Networks

Last Price:
$208.27
Seasonality Move:
-1.88%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.31
Seasonality Move:
1.75%
Buy
80
Palo Alto Networks (PANW) is a Buy

Is Palo Alto Networks a Buy, Sell or Hold?

  • The current Palo Alto Networks [PANW] share price is $200.03. The Score for PANW is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • PANW is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PANW Stock Price Chart

What is Palo Alto Networks's stock price today?

  • The Palo Alto Networks share price today is $200.03
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PANW is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

PANW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.74 Buy
Relative Strength Index (14 RSI): 64.87 Buy
Chaikin Money Flow: 10944941 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (177.22 - 194.86) Buy
Bollinger Bands (100): (176.73 - 196.37) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

PANW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 194.84 Buy
20-day SMA: 189.39 Buy
50-day SMA: 188.36 Buy
200-day SMA: 174.46 Buy
8-day EMA: 195.59 Buy
20-day EMA: 190.65 Buy
50-day EMA: 188.01 Buy
200-day EMA: 175.19 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Palo Alto Networks Earnings Growth & PANW Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.03 per share, an increase this year of $0.44 per share, and an increase next year of $0.41 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Palo Alto Networks Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):